{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T11:54:52Z","timestamp":1697370892941},"reference-count":31,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2005,4,7]],"date-time":"2005-04-07T00:00:00Z","timestamp":1112832000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arthritis &amp; Rheumatism"],"published-print":{"date-parts":[[2005,4,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>To evaluate the prevalence of hepatitis C virus (HCV) infection in patients with psoriatic arthritis (PsA), compared with patients affected by non HCV\u2010related rheumatic degenerative disorders.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>One\u2010hundred consecutive subjects with PsA, and a statistically comparable group of 100 consecutive patients with peripheral osteoarthritis (OA) or sciatica due to L4\u2013L5 or L5\u2013S1 herniated disc were tested for HCV infection with a third\u2010generation microparticle enzyme immunoassay (MEIA). Positive cases were submitted to a third\u2010generation recombinant immunoblot assay (RIBA) confirmatory test. Comparison between the HCV prevalence obtained in the 2 enrolled groups was performed using Fisher's exact test.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Anti\u2010HCV antibodies were found with the MEIA method, in 1 patient with PsA, and in 4 patients with OA or sciatica. The RIBA method confirmed MEIA results in all positive patients. The difference in HCV prevalence detected in the PsA group and in the control group was not statistically significant (<jats:italic>P<\/jats:italic> = 0.68). Furthermore, HCV prevalence in PsA patients was lower than the ones reported in different geographic areas of Italy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our present report does not confirm previous data that indicated an increased prevalence of HCV in PsA patients, and as a consequence, does not sustain a possible trigger role of HCV in cases of PsA. The absence of clinical or instrumental resources that consent a definite differential diagnosis between PsA and HCV\u2010related arthritis was outlined and analyzed.<\/jats:p><\/jats:sec>","DOI":"10.1002\/art.21079","type":"journal-article","created":{"date-parts":[[2005,4,7]],"date-time":"2005-04-07T15:08:50Z","timestamp":1112886530000},"page":"223-225","source":"Crossref","is-referenced-by-count":21,"title":["Hepatitis C virus infection in psoriatic arthritis"],"prefix":"10.1002","volume":"53","author":[{"given":"Carlo","family":"Palazzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignazio","family":"Olivieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio","family":"D'amico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorena","family":"D'agostino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Nicolucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernesta","family":"Pennese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Attilio","family":"Petricca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,4,7]]},"reference":[{"issue":"3","key":"e_1_2_5_2_2","first-page":"B101","article-title":"Rheumatic manifestations of hepatitis C virus infection","volume":"24","author":"Euller\u2010Ziegler L","year":"1995","journal-title":"Rheumatol Eur"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.57.12.728"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-0172(98)80043-7"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199910)42:10<2204::AID-ANR24>3.0.CO;2-D"},{"key":"e_1_2_5_6_2","first-page":"420","article-title":"Arthritis in patients with chronic hepatitis C virus infection","volume":"26","author":"Rivera J","year":"1999","journal-title":"J Rheumatol"},{"key":"e_1_2_5_7_2","first-page":"579","article-title":"Hepatitis C virus\u2010related arthritis: characteristics and response to therapy with interferon alpha","volume":"18","author":"Zuckerman E","year":"2000","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2003.12.006"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-857X(02)00097-2"},{"key":"e_1_2_5_10_2","doi-asserted-by":"crossref","first-page":"482","DOI":"10.2340\/0001555575482483","article-title":"Psoriasis and hepatitis C virus","volume":"75","author":"Yamamoto T","year":"1995","journal-title":"Acta Derm Venereol"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1996.tb02977.x"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1159\/000246673"},{"key":"e_1_2_5_13_2","first-page":"370","article-title":"Hepatitis C virus infection: prevalence in psoriasis and psoriatic arthritis","volume":"26","author":"Taglione E","year":"1999","journal-title":"J Rheumatol"},{"key":"e_1_2_5_14_2","first-page":"127","article-title":"Psoriatic arthritis (PSA): an analysis of 220 patients","volume":"62","author":"Gladman DD","year":"1987","journal-title":"QJM"},{"key":"e_1_2_5_15_2","first-page":"1345","volume-title":"Arthritis and allied conditions","author":"Bennet RM","year":"2001"},{"key":"e_1_2_5_16_2","first-page":"3","article-title":"Rheumatoid arthritis or psoriatic symmetric polyarthritis? A difficult differential diagnosis","volume":"20","author":"Palazzi C","year":"2002","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0049-0172(73)90035-8"},{"key":"e_1_2_5_18_2","first-page":"316","article-title":"Epatite C e artrite: studio clinico\u2010sierologico dell'artrite in pazienti con e senza sindrome crioglobulinemica","volume":"54","author":"Fadda P","year":"2002","journal-title":"Reumatismo"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-857X(02)00099-6"},{"key":"e_1_2_5_20_2","first-page":"719","article-title":"Possible involvement of group A streptococci in the pathogenesis of psoriatic arthritis","volume":"9","author":"Vasey FB","year":"1982","journal-title":"J Rheumatol"},{"key":"e_1_2_5_21_2","first-page":"461","article-title":"Anti\u2010enterobacteria antibodies in psoriatic arthritis","volume":"10","author":"Lapadula G","year":"1992","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_5_22_2","first-page":"610","article-title":"Use of antikeratin antibodies to distinguish between rheumatoid arthritis and polyarthritis associated with hepatitis C infection","volume":"27","author":"Kessel A","year":"2000","journal-title":"J Rheumatol"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1186\/ar1041"},{"key":"e_1_2_5_24_2","first-page":"979","article-title":"Hepatitis C infection presenting with rheumatic manifestations: a mimic of rheumatoid arthritis","volume":"23","author":"Lovy MR","year":"1996","journal-title":"J Rheumatol"},{"issue":"13","key":"e_1_2_5_25_2","first-page":"S33","article-title":"Hepatitis C virus as a lymphotropic agent: evidence and pathogenetic implications","volume":"13","author":"Zignego AL","year":"1995","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.1993.tb00782.x"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01740815"},{"key":"e_1_2_5_28_2","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1128\/JCM.37.7.2371-2372.1999","article-title":"Molecular epidemiology of hepatitis C virus infection in an area of hyperendemicity in southern Italy: a population\u2010based study","volume":"37","author":"Osella AR","year":"1999","journal-title":"J Clin Microbiol"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.1999.tb00073.x"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1010932832190"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-001-1197-4"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199905)42:5<1010::AID-ANR21>3.0.CO;2-H"}],"container-title":["Arthritis Care &amp; Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fart.21079","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/art.21079","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T12:14:32Z","timestamp":1697026472000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/art.21079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4,7]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,4,15]]}},"alternative-id":["10.1002\/art.21079"],"URL":"https:\/\/doi.org\/10.1002\/art.21079","archive":["Portico"],"relation":{},"ISSN":["0893-7524","1529-0123"],"issn-type":[{"value":"0893-7524","type":"print"},{"value":"1529-0123","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,4,7]]}}}